VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,185 | -10.6% | 81,212 | 0.0% | 0.18% | -9.1% |
| Q2 2023 | $2,445 | -6.9% | 81,212 | 0.0% | 0.20% | -11.7% |
| Q1 2023 | $2,627 | +11.3% | 81,212 | -1.5% | 0.22% | +7.7% |
| Q4 2022 | $2,361 | -99.9% | 82,412 | +0.1% | 0.21% | +15.6% |
| Q3 2022 | $1,985,000 | -12.1% | 82,312 | -0.2% | 0.18% | -5.8% |
| Q2 2022 | $2,257,000 | -28.6% | 82,451 | 0.0% | 0.19% | -14.4% |
| Q1 2022 | $3,161,000 | +19.7% | 82,451 | 0.0% | 0.22% | +19.4% |
| Q4 2021 | $2,640,000 | +8.7% | 82,451 | 0.0% | 0.19% | -1.6% |
| Q3 2021 | $2,429,000 | -13.3% | 82,451 | 0.0% | 0.19% | -13.7% |
| Q2 2021 | $2,801,000 | -7.6% | 82,451 | -11.7% | 0.22% | -14.1% |
| Q1 2021 | $3,033,000 | -3.1% | 93,351 | +7.4% | 0.26% | -8.9% |
| Q4 2020 | $3,130,000 | -8.0% | 86,886 | 0.0% | 0.28% | -17.4% |
| Q3 2020 | $3,402,000 | +6.7% | 86,886 | 0.0% | 0.34% | -3.1% |
| Q2 2020 | $3,187,000 | +64.7% | 86,886 | +3.5% | 0.35% | +35.7% |
| Q1 2020 | $1,935,000 | -21.3% | 83,971 | 0.0% | 0.26% | +0.4% |
| Q4 2019 | $2,459,000 | +8.7% | 83,971 | -0.8% | 0.26% | +2.8% |
| Q3 2019 | $2,262,000 | +4.5% | 84,671 | +0.0% | 0.25% | +5.5% |
| Q2 2019 | $2,164,000 | +5.5% | 84,657 | -7.5% | 0.24% | +3.9% |
| Q1 2019 | $2,051,000 | +6.6% | 91,487 | +0.3% | 0.23% | -6.6% |
| Q4 2018 | $1,924,000 | -8.4% | 91,232 | -19.5% | 0.24% | +3.8% |
| Q3 2018 | $2,100,000 | -29.9% | 113,367 | -15.6% | 0.24% | -34.7% |
| Q2 2018 | $2,996,000 | +4.0% | 134,302 | +2.4% | 0.36% | -0.6% |
| Q1 2018 | $2,881,000 | -3.7% | 131,094 | +1.8% | 0.36% | -2.4% |
| Q4 2017 | $2,993,000 | -0.0% | 128,796 | -1.2% | 0.37% | -2.9% |
| Q3 2017 | $2,994,000 | +3.0% | 130,386 | -1.0% | 0.38% | -0.5% |
| Q2 2017 | $2,908,000 | -11.5% | 131,715 | -8.5% | 0.38% | -14.1% |
| Q1 2017 | $3,285,000 | +9.7% | 143,996 | +0.6% | 0.45% | +3.2% |
| Q4 2016 | $2,994,000 | -15.5% | 143,096 | +6.7% | 0.43% | -18.6% |
| Q3 2016 | $3,544,000 | -4.7% | 134,096 | -0.1% | 0.53% | -7.5% |
| Q2 2016 | $3,719,000 | – | 134,216 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |